Drugs / DOTANOC
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT02824419 | May 2016 → Feb 2017 | pulmonary sarcoidosis | Turku University Hospital | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DOTANOC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02824419 ↗ |
| Known as | Dota-nal3-octreotide | ChEMBL registry synonym — accepted as the source's own label CHEMBL4297373 ↗ |
| Modality | Small molecule | — CHEMBL4297373 ↗ |